Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £787,600 | £877,100 | £1,000,300 | £908,300 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Cost of Goods Sold | £275,900 | £301,900 | £382,200 | £329,500 |
| Gross Profit | £511,700 | £575,200 | £618,100 | £578,800 |
| % Margin | 65% | 65.6% | 61.8% | 63.7% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £100 | £0 | £0 | £0 |
| SG&A Expenses | £100 | £448,800 | £373,100 | £309,400 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £455,500 | £0 | £0 | £0 |
| Operating Expenses | £455,600 | £448,800 | £427,300 | £352,700 |
| Operating Income | £56,100 | £126,400 | £180,800 | £228,100 |
| % Margin | 7.1% | 14.4% | 18.1% | 25.1% |
| Other Income/Exp. Net | -£47,300 | -£33,400 | -£31,400 | -£48,700 |
| Pre-Tax Income | £8,800 | £93,000 | £159,400 | £214,300 |
| Tax Expense | £4,300 | £23,800 | £30,500 | £33,100 |
| Net Income | £4,500 | £69,200 | £128,900 | £181,200 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46.2% | -27.8% | – |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| Weighted Avg Shares Out | 962,300 | 988,571 | 1,000,500 | 1,000,100 |
| Weighted Avg Shares Out Dil | 974,100 | 985,600 | 1,001,200 | 1,002,900 |
| Supplemental Information | – | – | – | – |
| Interest Income | £3,800 | £1,800 | £1,900 | £100 |
| Interest Expense | £29,200 | £31,000 | £17,500 | £13,800 |
| Depreciation & Amortization | £72,500 | £72,300 | £54,200 | £36,700 |
| EBITDA | £110,500 | £196,300 | £235,000 | £265,100 |
| % Margin | 14% | 22.4% | 23.5% | 29.2% |